Mao, YoushengYu, ZhentaoYou, BinFang, WentaoBadgwell, BrianBerry, Mark F.Ceppa, DuyKhanh P.Chen, ChunChen, HaiquanCuesta, Miguel A.D’Journo, Xavier BenoitEslick, Guy D.Fu, JianhuaFu, XiangningGao, ShugengHe, JianxingHe, JieHuang, YunchaoJiang, GeningJiang, ZhongminKim, Jae Y.Li, DanqingLi, HuiLi, ShanqingLiu, DeruoLiu, LunxuLiu, YongyuLi, XiaofeiLi, YinMao, WeiminMolena, DanielaMorse, Christopher R.Novoa, Nuria M.Tan, LijieTan, QunyouToker, AlperTong, TiWang, QunWeksler, BennyXu, LinXu, ShidongYan, TianshengZhang, LanjunZhang, XingyiZhang, XunZhang, ZhuZhi, XiuyiZhou, Qinghua2019-09-162019-09-162019-01Mao, Y., Yu, Z., You, B., Fang, W., Badgwell, B., Berry, M. F., … Zhou, Q. (2019). Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma. Journal of thoracic disease, 11(1), 319–328. doi:10.21037/jtd.2018.12.07https://hdl.handle.net/1805/20929en-USPublisher PolicySurgical approachesThoracic esophageal carcinomaNeoadjuvant therapyRecommendations for patient selectionPatient survival benefitArticle